Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) — Stella

Home/Tetraplegia/Tetraparesis/Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

View on ClinicalTrials.gov

Recruiting

Back to Tetraplegia/Tetraparesis trials

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Johns Hopkins Medicine, Baltimore, Maryland

Key details

Sponsor

Johns Hopkins University

Collaborators

Blackrock Neurotech, JHU Applied Physics Laboratory

Enrollment target

~5 participants

Started

June 2026

Primary completion

June 2028

Age range

18 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.